Blood endocan as a biomarker for breast cancer recurrence
Endocan was reported to affect breast cancer patients negatively and was able to be detected from patients' blood. This study aimed to investigate if the measurement of blood endocan in breast cancer patients with high ESM1 expression could be an effective tool to detect postoperative recurrenc...
Gespeichert in:
Veröffentlicht in: | Cancer biomarkers : section A of Disease markers 2024-01, Vol.41 (2), p.145-154 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!